SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

IPCA LABORATORIES

BSE: 524494 29 Jun 2025
Healthcare
₹ 1338.45
Ipca Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IPCA LABORATORIES - Share Price & Details

Market Cap
₹34,362
High /Low
1,758 / 1,052
Stock P/E
39.6
Book Value
₹274.0
Dividend Yield
0.3
ROCE
15.0
ROE
₹13.1
Face Value
1.0
PEG Ratio
5.05
EVEBITDA
₹19.4
Debt
1,363
CMP / FCF
71.5
Debt to equity
₹0.2
NP Ann
785
High price all time
1,758
Piotroski score
₹9.0
Graham Number
423.0
No. Eq. Shares
25.4
Net CF
₹169
Net profit
785
Price to book value
4.95
Interest Coverage
₹16.7
Low price all time
23.5
Industry PE
32.0
Reserves
₹6,923
Free Cash Flow
₹551

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
IPCA LABORATORIES LTD.NANANANA34,36239.6
AJANTA PHARMA LTD.11885.22252.611704.1183148734.4
Aster DM Healthcare Limited6089.9610.75738.61.223047676.4

Peer Comparison Chart


About IPCA LABORATORIES

Ipca Laboratories Ltd., with Security Code 524494, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD

(16 Jun 2025)
Ipca Labs has announced that Dr Nagaji Ambabhai Vekariya has joined the Company as President - CRD. Dr. Vekariya brings with him a...
Read more →

Ipca Laboratories Ltd soars 1.25%, Gains for third straight session

(12 Jun 2025)
Ipca Laboratories Ltd is quoting at Rs 1406.8, up 1.25% on the day as on 12:49 IST on the NSE. The stock is up 17.25% in last one year as...
Read more →

Dr Reddys Laboratories Ltd up for third consecutive session

(12 Jun 2025)
Dr Reddys Laboratories Ltd is quoting at Rs 1364.9, up 1.02% on the day as on 12:49 IST on the NSE. The stock is up 11.95% in last one year...
Read more →

Pharma Stocks to Buy: Brokerage bullish on Sun Pharma, Dr Reddy's Labs, IPCA Labs; note down targets

(05 Jun 2025)
The pharmaceutical coverage reported 13 per cent YoY topline growth and the domestic sub-segment grew 11 per cent YoY, driven by traction in...
Read more →

IPCA Labs Q4 Results: Revenue and margin grow from last year; dividend announced

(29 May 2025)
Pharma major IPCA Laboratories Ltd. reported its March quarter earnings on Thursday, May 29, where its net profit rose 14% year-on-year to...
Read more →

BOARD OF IPCA LABORATORIES RECOMMENDS FINAL DIVIDEND

(29 May 2025)
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2025, inter alia, have recommended the...
Read more →